Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation.

B Mellström, L Bertilsson, Y C Lou

    Clinical Pharmacology and Therapeutics
    |October 1, 1983
    PubMed
    Summary

    Amitriptyline demethylation to nortriptyline was studied in healthy subjects. This metabolic pathway did not correlate with debrisoquine hydroxylation capacity, indicating distinct metabolic routes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acetylation of procaine amide in man studied with a new gas chromatographic method.

    British journal of clinical pharmacology·2012
    Same author

    Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.

    Haemophilia : the official journal of the World Federation of Hemophilia·2011
    Same author

    Historical perspectives: drug interactions - it all began with cheese.

    Journal of internal medicine·2010
    Same author

    Vaccination of children--a systematic review.

    Acta paediatrica (Oslo, Norway : 1992)·2010
    Same author

    Socio-cultural practices of deciduous canine tooth bud removal among Maasai children.

    International dental journal·2010
    Same author

    Randomized trials or population-based registries.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2007

    Area of Science:

    • Pharmacokinetics
    • Drug Metabolism
    • Clinical Pharmacology

    Background:

    • Amitriptyline (AT) is a widely used antidepressant.
    • Its metabolism involves demethylation to nortriptyline (NT).
    • Debrisoquine hydroxylation capacity is a marker for CYP2D6 activity.

    Purpose of the Study:

    • To investigate the relationship between amitriptyline (AT) demethylation and debrisoquine (D) hydroxylation capacity.
    • To determine if CYP2D6 phenotype influences AT to NT metabolic conversion.

    Main Methods:

    • Nine healthy subjects were phenotyped for debrisoquine hydroxylation.
    • Amitriptyline demethylation was assessed by comparing plasma AUCs of NT after single oral doses of AT and NT.
    • Urine analysis for D and 4-hydroxy-D was performed.

    Related Experiment Videos

    Main Results:

    • Plasma clearance of AT by demethylation was calculated.
    • No significant correlation was found between AT demethylation and the urinary ratio of D to 4-hydroxy-D (rs = -0.55).

    Conclusions:

    • Amitriptyline demethylation is not directly dependent on the debrisoquine hydroxylation pathway.
    • These findings suggest that different cytochrome P450 enzymes may be primarily involved in AT demethylation compared to D hydroxylation.